Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ALTEROLA BIOTECH, INC.

(ABTI)
SummaryQuotesChartsNewsCompany 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

ALTEROLA BIOTECH INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year (form 8-K)

06/09/2021 | 01:55pm EDT

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On May 28, 2021, the Company's Board of Directors approved a change in the Company's fiscal year-end from September 30 to March 31. The Company will file a transition report on Form 10-K for the period ended March 31, 2021, in accordance with SEC rules and regulations. All subsequent fiscal years for the Company will be from April 1 to March 31.

3

© Edgar Online, source Glimpses

All news about ALTEROLA BIOTECH, INC.
08/19ALTEROLA BIOTECH : Management's Discussion and Analysis of Financial Condition and Results..
AQ
08/02ALTEROLA BIOTECH : acquires ABTI pharma ltd
AQ
06/21ALTEROLA BIOTECH INC. : Change in Directors or Principal Officers (form 8-K)
AQ
06/16ALTEROLA BIOTECH INC. : Entry into a Material Definitive Agreement, Completion of Acquisit..
AQ
06/16ABTI Pharma Limited completed the acquisition of Alterola Biotech, Inc. in reverse merg..
CI
06/09ALTEROLA BIOTECH : 10-KT - Management's Discussion and Analysis of Financial Condition and..
AQ
06/09Alterola Biotech, Inc. Reports Earnings Results for the Half Year Ended March 31, 2021
CI
06/09ALTEROLA BIOTECH INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year (f..
AQ
05/28ALTEROLA BIOTECH : Management's Discussion and Analysis of Financial Condition and Results..
AQ
05/25ALTEROLA BIOTECH INC. : Entry into a Material Definitive Agreement, Financial Statements a..
AQ
More news
Chart ALTEROLA BIOTECH, INC.
Duration : Period :
Alterola Biotech, Inc. Technical Analysis Chart | ABTI | US02152V1035 | MarketScreener
Managers and Directors
Seamus McAuley Chief Executive Officer
Larson Elmore Vice Chairman, CFO, Secretary & CAO
Timothy Paul Rogers Chairman
Colin Stott Chief Operating Officer & Director
Dominic Schiller Director
Sector and Competitors
1st jan.Capi. (M$)
ALTEROLA BIOTECH, INC.0.00%960
GILEAD SCIENCES, INC.21.80%88 970
BIONTECH SE315.86%81 878
WUXI APPTEC CO., LTD.35.75%69 413
REGENERON PHARMACEUTICALS32.66%66 632
VERTEX PHARMACEUTICALS-21.44%48 168